Semin Respir Crit Care Med 2019; 40(03): 394-401
DOI: 10.1055/s-0039-1695058
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

What's the Score? Do Pleural Effusion Clinical Scoring Systems Help in Management of Disease?

Peter Grendelmeier
1   Oxford Respiratory Trials Unit, Oxford Centre for Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Churchill Hospital Site, Oxford, England, United Kingdom
,
Najib M. Rahman
1   Oxford Respiratory Trials Unit, Oxford Centre for Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Churchill Hospital Site, Oxford, England, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
16 September 2019 (online)

Zoom Image

Abstract

Pleural effusion is a common condition, affecting over 3,000 people per million population every year. More than 50 causes of pleural effusions are known, including pleural infection and malignant pleural disease. These conditions place a large burden on healthcare systems with one-fourth of patients with pleural infection having a length of hospital stay of more than 1 month. Malignant pleural effusion represents advanced malignant disease with a correspondingly high mortality. Prognostic models using clinical information in combination with blood or pleural fluid biomarkers predicting survival and other outcome measures are therefore a priority in improving clinical care, and potentially outcomes. Identifying patients with poor prognosis may help avoid discomfort and unnecessary interventions at the end of their lives, while, on the other hand, individuals with scores predicting a particularly good prognosis might be selected for more aggressive early treatment. Such scores must be based on data representing routine practice in a general hospital and variables chosen based on their clinical availability at clinical decision points (i.e., before treatment is instituted), making the findings widely applicable.